A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. - Wikidata - wikimedia - TriplyDB

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

http://www.wikidata.org/entity/Q53391715

about

Alzheimer mechanisms and therapeutic strategies Synapses and Alzheimer's disease Alzheimer's in 3D culture: challenges and perspectives Brain PET in the diagnosis of Alzheimer's disease Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17 Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities Additional mechanisms conferring genetic susceptibility to Alzheimer's disease Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study The Japanese Mutant Aβ (ΔE22-Aβ1−39) Forms Fibrils Instantaneously, with Low-Thioflavin T Fluorescence: Seeding of Wild-Type Aβ1−40into Atypical Fibrils by ΔE22-Aβ1−39 Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment.Comparisons with amyloid-β reveal an aspartate residue that stabilizes fibrils of the aortic amyloid peptide medin.Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice.Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice Clinical genetics of Alzheimer's disease Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies Current status on Alzheimer disease molecular genetics: from past, to present, to future.Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils.Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.Neuron loss in transgenic mouse models of Alzheimer's disease Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.Probing the biology of Alzheimer's disease in mice.Design of β-amyloid aggregation inhibitors from a predicted structural motif.Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders

P2860

Q22252311-2F1C4348-31A9-45A4-9356-861E29039107 Q26269868-5FB4DA17-BC80-4B28-A8E3-06F55CE622F9 Q26801081-B5BA7315-D19A-438D-80B5-7BF6E07E8511 Q27011549-F27FDA3F-F205-462E-A0F8-8F4F39BAB5F1 Q27301267-F17E82F4-BF70-4E97-B972-6A2E26F9681C Q27345314-5D2BEFF0-0ACC-42E6-A1CF-D5F49EAC9F39 Q28066391-1F722DA3-4691-47D9-AEF7-62C9ACC8AF44 Q28078428-BB916AEA-DE7E-4CDA-8348-D5A7EFC57B6D Q28082768-2429F90E-BE95-4702-B3CB-B98D6D8CC6BF Q28083990-E5AED134-641E-411D-A1CF-57E133966AA8 Q28086879-12CBF029-B7BB-4285-AA69-DB8D034979A5 Q28391511-4EA121C4-72B2-44D3-9660-EC718EBCF492 Q28817628-E898E86A-CE83-48F7-AA02-2DC53EE323E8 Q29544432-56E5CA64-8CEA-4698-B42A-568A102EFB72 Q30153519-000A0C8B-AB40-4509-83EF-777457DA43BC Q30371013-DB90F22B-4D9C-4047-8242-D71E77BADAB2 Q30497246-06F06B3B-C953-49BB-875D-A9B1F74F8424 Q30534746-410B645C-EFBB-4A1F-939E-4E4C11E956CA Q33621850-A49E63C7-7AD5-4E8A-97CE-D9CA19477B61 Q33715954-9574CFA8-2344-4327-B61D-EA9398FAAD23 Q33737786-AFA7DA06-D86A-489F-B608-29AD2C555EDD Q33745216-D0F238A5-C765-4B61-A8F2-2ACDADF42E44 Q33747695-D0163C33-C998-450F-B7D4-C49D750DC1E5 Q33871345-3C8C2430-340E-49E9-A39D-3BE25795509C Q33893017-E23EFE50-B4DA-4997-AB69-6FA45FAA4C4A Q34003950-F69490BD-F15F-4B09-A3CF-655DF52524F6 Q34022483-F9E8CE1F-5339-4B82-B541-AB2280AD345D Q34084687-3B99E5D1-7484-4AFA-87AD-B20700098B08 Q34123651-98E18FFB-285A-4D79-88AA-9B9589FC75F1 Q34143614-D609CD07-7176-4D8A-A7F2-7CBBD73CB5B6 Q34157421-E9E239DF-C01F-42C9-A608-77A2E7A194C7 Q34206962-17116FDC-58C7-4161-9774-9510F3F19355 Q34261600-C3A27F69-9E0F-4DC7-9202-16C0D845DFD1 Q34410122-7B94F0A3-ED68-4D82-B2AB-24DDFE305D80 Q34481815-480D2ED1-A98F-4133-991B-ECCA0E755487 Q34552263-E5ED6C9C-EB9C-4FDB-8098-5B42D493EF60 Q34694664-68C22B0D-1CFC-4059-AD0D-31DE684B5F7D Q35002786-828D04C3-E712-4C80-BCC1-ED7DD87F64D5 Q35157679-8363AE8E-B727-47A4-AA48-941D4CCDC362 Q35542857-C16DE148-C200-4AF4-BA02-5E3550548842

P2860

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

http://www.wikidata.org/entity/Q53391715

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@en

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@nl

type

label

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@en

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@nl

prefLabel

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@en

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@nl

P1433

Q53391715-E92AB24E-AC81-4586-85D1-040401CEBF3B

P1476

Q53391715-7036F6B0-4009-45DE-9170-09CA8A7724DE

P2093

Q53391715-0ECEC6A4-8130-493E-8DEB-C9C7EA1030BE

Q53391715-4E6B6130-216F-4167-8602-6AC0E94B02A1

Q53391715-5A6ACAF7-7C2D-4C10-9D08-487282036D55

Q53391715-798C8AF3-376A-4F84-A6A4-166211016A6F

Q53391715-9C54C0D5-C6CA-47AF-A28A-E63F95521DE8

Q53391715-9FB86890-D416-43CD-B743-AFC2B71729DF

Q53391715-A1DF611D-98CC-47BE-BB8C-74013BA5DEE4

Q53391715-AACA0501-6F2A-494F-8D77-3DF3B574D53A

Q53391715-CD5EEE20-E4D9-4FE5-B305-A9173584A6A2

Q53391715-D8061363-6584-419C-94B7-CE3923ADE2EF

P304

Q53391715-6E5668C1-74A2-4F93-9C9B-DE02AF225B7E

P31

Q53391715-CC9F7010-35BA-4B3C-A5BA-9532D6D21A3D

P356

Q53391715-E00D4119-F88D-4D02-B2F8-D6DD1C88C4F7

P433

Q53391715-4088620D-0BC1-47A7-8C5B-2F81F6605BFC

P478

Q53391715-DB261FF6-7057-4C38-B0B3-24465E1E6BA0

P577

Q53391715-068EC05F-2939-46E8-BFC2-A7EEFCA9BA38

P698

Q53391715-4859365D-D569-4E18-BCAD-3B5673AF42FD

P921

Q53391715-076DBE96-2F7C-427E-A262-609133277DDD

Q53391715-D6E7D0BB-46C4-4533-9FB0-A13B5C0157E1

P356

P1433

Annals of Neurology

P1476

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.

@en

P2093

Akiko Fukushima

http://www.w3.org/2001/XMLSchema#string

Eito Yoshioka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mori

http://www.w3.org/2001/XMLSchema#string

Hiroshi Takuma

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shimada

http://www.w3.org/2001/XMLSchema#string

Hyoue Kanemitsu

http://www.w3.org/2001/XMLSchema#string

Masaki Imagawa

http://www.w3.org/2001/XMLSchema#string

Rie Teraoka

http://www.w3.org/2001/XMLSchema#string

Ryozo Kuwano

http://www.w3.org/2001/XMLSchema#string

Suzuka Ataka

http://www.w3.org/2001/XMLSchema#string

P304

377-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21321

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18300294

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease